|Generic Name||Brand Name|
|naltrexone||ReVia [formerly called Trexan], Relistor|
Naltrexone is available in pill form. Relistor is taken as a shot (injection) into a muscle (intramuscular) once a month.
Naltrexone is an opioid antagonist that interferes with the part of the brain involved in producing the pleasure you get from drinking alcohol or taking other drugs.
Naltrexone is used to treat alcohol or opioid drug dependence. It reduces the pleasurable effects of alcohol and helps block the effects of narcotic (opioid) drugs, such as heroin. It may help reduce your cravings for opioid drugs.
Naltrexone can be used alone or combined with other medicines that affect the brain, such as medicines for depression or acamprosate. Acamprosate often is used to treat alcohol dependence.
Naltrexone can help prevent drug cravings and relapse, but you still need other treatments, such as counselling, to help you recover from drug addiction.
Naltrexone can cause nausea, dizziness, and fatigue. It also can cause headaches and make you feel anxious, sleepy, or nervous.
See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)
You might develop liver damage if you have liver disease (such as hepatitis, cirrhosis, or liver failure) and take too much naltrexone.
This medicine will cause withdrawal symptoms if you are taking opioids drugs. If you have taken opioids in the past 7 to 10 days, talk to your doctor before taking naltrexone.
You might need to take naltrexone for several months to effectively prevent relapse.
Relistor, a once-a-month injection of this medicine, is a form of naltrexone useful for people who have a hard time deciding whether to take the medicine each day.
The U.S. Food and Drug Administration (FDA) has issued an advisory about injectable forms of naltrexone. You may have a skin reaction at the injection site, the place where the shot is given. Call your doctor if you notice any skin change at the injection site, such as swelling, tenderness, redness, or pain, that does not improve or gets worse within 2 weeks.
- Srisurapanont M, Jarusuraisin N (2005). Opioid antagonists for alcohol dependence. Cochrane Database of Systematic Reviews (1).
- Kiefer F, et al. (2003). Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: A double-blind, placebo-controlled study. Archives of General Psychiatry, 60(1): 92–99.
Last Revised: April 19, 2012
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information.